-
3201
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
Published 2022-01-01“…Real-world evidence (RWE) studies were identified through a systematic literature review conducted between January 2012 and July 2020, using Embase, MEDLINE, and the websites of cardiological, hematological, and oncological associations. …”
Get full text
Article -
3202
-
3203
Safety of Colonoscopies in Patients on Advanced Heart Failure Therapies Who Received a Heart Transplant
Published 2025-01-01Get full text
Article -
3204
An atypical case of infective endocarditis initially diagnosed as myopericarditis
Published 2025-03-01“…Case report: We present the case of a 36-year-old male who was initially hospitalized for myocarditis and discharged on medications with cardiology follow-up planned. Twelve days later, the patient was readmitted with recurring chest pain. …”
Get full text
Article -
3205
Social, Racial, and Economic Disparities Affecting Outcomes of Hypertensive Adolescents
Published 2025-01-01“…ABSTRACT Essential hypertension is one of the most common conditions managed in pediatric cardiology and can result in lasting deleterious effects on the cardiovascular system. …”
Get full text
Article -
3206
-
3207
Left Atrial Appendage Occlusion: Expanding Indications and New Developments
Published 2025-01-01Get full text
Article -
3208
Drug consumption and treatment costs of the glaucoma therapy in the Republic of Serbia
Published 2024-01-01Get full text
Article -
3209
-
3210
-
3211
-
3212
Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis
Published 2022-01-01“…**Objectives:** To estimate the effects of delaying treatment on the risk of cardiovascular-related hospitalization and on costs for patients who meet the criteria for secondary prevention as specified in the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines for Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. …”
Get full text
Article -
3213
-
3214
-
3215
-
3216
Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Published 2021-06-01“…The management of combined NAFLD-T2D requires a close inter-specialty involvement from hepatology, gastroenterology, endocrinology and cardiology. This interdisciplinary problem can be tackled through persuasive lifestyle recommendations and choosing rational medication strategies with a proved hepatoprotective efficacy.…”
Get full text
Article -
3217
Ischemic Heart Disease Prognosis: A Hybrid Residual Attention-Enhanced LSTM Model
Published 2025-01-01Get full text
Article -
3218
-
3219
-
3220